[ad_1]
Vilnius Santara clinics have reported that doctors who were vaccinated on December 27 will be vaccinated on Sunday. Then it was announced that there were 745 of them.
In the Kaunas clinics, the booster vaccination also started on Sunday and will continue on other days for those employees who have already passed three weeks after the first vaccination.
On Sunday, 330 employees were vaccinated at the Kaunas clinics, the Kaunas clinics announced.
Šarūnas Mačinskas, Head of the Outpatient Services Coordination Service of the Kaunas Clinics, states that 4,675 employees of the Kaunas Clinics have been vaccinated with the first dose of the COVID-19 vaccine. The second dose will be given to the same number of doctors as those who became infected with COVID-19 after the first vaccine.
“Workers who have been diagnosed with COVID-19 infection after the first dose of the vaccine will not be vaccinated now. Revaccination is delayed and will be administered 90 days after detection of COVID-19 infection. After the first vaccination, 7 employees of the Kaunas clinics became infected with COVID-19, ”says Š. Machinsk.
The second dose of the COVID-19 vaccine was also vaccinated on Sunday by the head of the Second Department of COVID-19 Disease Clinics of Kaunas. nurse administrator Jolanta Litvinienė, who became the first vaccinated medical worker in Kaunas on December 27. “After getting vaccinated, I feel good and have done everything possible. After the first dose of the COVID-19 vaccine, I didn’t feel any side effects, just a little pain at the injection site, ”says J. Litvinienė.
According to Š. In Machinsk, revaccination is organized in the same way as the first vaccination. “Health professionals who were the first to be vaccinated are invited to receive a second dose of COVID-19, after being screened for COVID-19 and other signs of acute upper respiratory infection,” explains Š. Machinsk.
Vaccination in Kaunas clinics is organized according to the procedure approved by the Minister of Health. Vaccination is mainly administered to workers most at risk of COVID-19: those who work in the COVID-19 disease rooms, emergency and reception, resuscitation, intensive care units, groups of heart attacks, strokes and multiple injuries, transplants, oncology and hematology day hospitals and emergency medical care. in the departments of surgery, endoscopy, anesthesiology, hemodialysis, obstetrics and gynecology, and subsequently all the rest of the hospital staff who comply with the priorities set in the procedure.
Health Minister Aistė Šuksta told BNS on Friday evening that if it became clear that COVID-19 vaccine manufacturers BioNTech and Pfizer had reduced the planned quantities of the vaccine to be delivered in the near future, the vaccine would be used only for the booster shot for the second week of February.
Meanwhile, the Moderna vaccine will be used for further vaccination of priority groups.
On December 27, CONID-19, developed by BioNTech and Pfizer at five central treatment facilities in the country, will be the first to be vaccinated.
This vaccine is administered twice with an interval of three weeks after the first vaccination and adequate protection of the immune system is achieved one week after the second vaccination.
As announced by the Health Ministry on Friday, Pfizer announced that 54,405 doses of the vaccine will be delivered instead of the planned 108,810 doses over the next four weeks.
Based on available data, Pfizer has temporarily reduced the supply of COVID-19 while reviewing its technology processes.
According to the ministry, a representative from BioNTech and Pfizer assures that the number of doses of vaccines that will be delivered later will increase. The manufacturer is committed to providing information on the exact number of vaccines that will be administered in the near future.
Vaccination priorities will not change and vaccination will continue as planned, only longer than planned.
According to the ministry, the expected delivery volumes are reduced for all countries of the European Union.
The total quantity of BioNTech and Pfizer vaccines ordered by Lithuania is 3.1 million. and will not change as a result of this temporary reduction in supply.
No part of this publication may be reproduced without the written permission of ELTA.
[ad_2]
